19Jun
Healthcare & Life Sciences Private Equity Deal Tracker: H.I.G BioHealth Sells Vertiflex to Boston Scientific
H.I.G. BioHealth Partners, the life-science investment affiliate of H.I.G. Capital, has announced the sale of Vertiflex to Boston Scientific. The total equity value of the sale is approximately $465 million in cash, with additional payments...
By:
McGuireWoods LLP
Related
On December 10, 2019, the FTC and CFPB hosted a public workshop on issues affecting the accuracy of ...
Read More >
On April 1, 2019, the U.S. Department of Labor issued proposed regulations clarifying its interpreta...
Read More >
Employers beware: New Jersey’s salary history ban, signed this past summer, takes effect on January...
Read More >
Most state mortgage finance, consumer credit, collection agency, sale finance, and money service bus...
Read More >
The US Supreme Court ruled on January 27 that the administration can begin to implement the public c...
Read More >
This is the third blog by our Trade Secrets , Computer Fraud & Non-Competes team dealing with Washin...
Read More >